For Oncology Nurses: Non-Small Cell Lung Cancer with a ROS1 Fusion — An Interview with Dr Alexander E Drilon

Oncology Today with Dr Neil Love · Sep 30, 2026 · 58m

Featuring an interview with Dr Alexander E Drilon, including the following topics:

Overview of targetable biomarkers in lung cancer (0:00)

Biomarker testing for genomic alterations in lung cancer (5:24)

Overview of ROS1 alterations in lung cancer (13:44)

Efficacy data with ROS1 inhibitors for lung cancer (17:02)

Safety data with ROS1 inhibitors for lung cancer (21:15)

Case: A woman in her early 50s with a history of non-small cell lung cancer (NSCLC) undergoes biomarker testing to reveal a ROS1 fusion (28:56)

Case: A man in his late teens diagnosed with de novo advanced NSCLC with a ROS1…